Thorough QT/QTc trial of laninamivir in volunteers.
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2014
Price : $35 *
At a glance
- Drugs Laninamivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Biota Pharmaceuticals
- 27 Sep 2014 Status changed from unconfirmed to completed.
- 27 Sep 2014 New trial record
- 19 Nov 2013 Data from this trial will support a New Drug Application for laninamivir, according to a Biota Pharmaceuticals media release.